PTPN11 and neoplasm: By successfully blocking the PD-1/PD-L1 checkpoint signal, adoptively transferred SHP099 packed T cells in a solid tumor model provided total tumor eradication and persistent immunological memory against tumor rechallenging in all subjects treated in a solid tumor model.110 They show that combining T-cell treatment with SHP2 inhibition is an approach to therapy that has assurance.